Glenn Wilkins - Wednesday, June 20, 2018 Neovasc Inc. 09:47 AM EST - Neovasc Inc. : Announced the first U.S. patient has been implanted with a Neovasc Reducer™, a CE-Marked medical device for the treatment of refractory angina. Neovasc Inc. shares T.NVCN are trading up $0.005 at $0.05.